Rudy Li Stock Analyst Profile - Chardan Capital Research Coverage - Stocknear

Rudy Li

Stock Analyst at Chardan Capital

(5)
# 201
Out of 5,493 analysts
28
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

10 Stocks

Name Action PT Current % Upside Ratings Updated
IMUX Immunic
Initiates Coverage On: Buy
3
0.94 219.15% 1 Sep 29, 2025
ANRO Alto Neuroscience
Initiates Coverage On: Buy
15
3.95 279.75% 1 Sep 29, 2025
RVPH Reviva Pharmaceutica...
Initiates Coverage On: Buy
2
n/a n/a 1 Sep 29, 2025
PRTA Prothena Corp
Maintains: Buy
18 18
9.41 91.29% 7 Aug 28, 2025
STOK Stoke Therapeutics
Maintains: Buy
24 24
24.14 -0.58% 4 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 55
37.98 44.81% 3 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 30
23.26 28.98% 3 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 20
10.67 87.44% 4 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 80
52.44 52.56% 2 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 80
52.72 51.75% 2 May 21, 2025